Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02)

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue 5, 2002, Pages 488-494

  Amendola, Alessandra ^a   Bordi, Licia ^a   Angeletti, Claudio ^a   Visco Comandini, Ubaldo ^a   Abbate, Isabella ^b   Cappiello, Giuseppina ^b   Budabbus, Mohamed A ^c   Eljhawi, Osama A ^c   Mehabresh, Mahdi I ^c   Girardi, Enrico ^a   Antinori, Andrea ^a   Ippolito, Giuseppe ^a   Capobianchi, Maria R ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

^c Embassy of the Popular Jamajria of Libya   (Italy)

Author keywords

A G recombinant HIV 1; Bayer Versant; Circulating recombinant form (CRF); HIV 1 subtypes; Organon Teknika NucliSens; Roche Amplicor Monitor; Viral load

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC KIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS LOAD; VIRUS TYPING;

EID: 0037114845     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200212150-00006     Document Type: Article

References (50)

1. Korber B, Theiler J, Wolinsky S. Limitations of a molecular clock applied to considerations of HIV-1. Science 1998;280:1868-71.
2. Kuiken C, Foley B, Han B, et al. Human retroviruses and AIDS. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM: Theoretical Biology and Biophysics Group, 1999.
3. Janssens W, Buve A, Nkengasong JN. The puzzle of HIV-1 subtypes in Africa. AIDS 1997;11:705-12.
4. Carr JK, Salminen MO, Albert J, et al. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 1998;247:22-31.
5. Carr J. Foley B, Leitner T, et al. Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic. In: Human Retrovirus and AIDS, pt 3. Los Alamos NM: Los Alamos National Laboratory, 1999.
6. Janssens W, Heyndrickx L, Van der Auwera G, et al. Interpatient genetic variability of HIV-1 group O. AIDS 1999;13:41-8.
7. McCutchan FE. Understanding the genetic diversity of HIV-1. AIDS 2001;14 (Suppl 3):S31-44.
8. Janssens W, Heyndrickx L. Fransen K, et al. Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retroviruses 1994;10:877-9.
9. Nasioulas G, Paraskevis D, Magiorkinis E, et al. Molecular analysis of the full-length genome of HIV type 1 subtype I: Evidence of A/G/I recombination. AIDS Res Hum Retroviruses 1999;15:745-58.
10. Peeters M, Liegeois F, Torimiro N, et al. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol 1999;73:7368-75.
11. Montavon C, Toure-Kane C, Liegeois F, et al. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr 2000;23:363-74.
12. Peeters M, Gueye A, Mboup S, et al. Geographical distribution of HIV-1 group O viruses in Africa. AIDS 1997;11:493-8.
13. Mauclere P, Loussert-Ajaka I, Damond F, et al. Serological and virological characterization of HIV-1 group O infection in Cameroon. AIDS 1997;11:445-53.
14. Workshop report from the European Commission and the Joint United Nations Program on HIV/AIDS. 1997. HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines and diagnostics. AIDS 1997;1:17-36.
15. Montavon C, Bibollet-Ruche F, Robertson D, et al. The identification of a complex A/G/I/J recombinant HIV-1 virus in different West African countries. AIDS Res Hum Retroviruses 1999;15:1707-12.
16. Osmanov S, Pattou C, Walzer N, et al. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002;29:184-90.
17. Brodine SK, Mascola JR, Weiss PJ, et al. Detection of diverse H1V-1 genetic subtypes in the USA. Lancet 1995;346:1198-9.
18. Rayfield MA, Sullivan P, Bandea CI, et al. HIV-1 group O virus identified for the first time in the US. Emerg Infect Dis 1996;2:209-12.
19. Clewley JP, Arnold C, Barlow KL, et al. Diverse HIV-1 genetic subtypes in UK. Lancet 1996;347:1487.
20. Fransen K, Buve A, Nkengasong JN, et al. Longstanding presence in Belgians of multiple nonB HIV-1 subtypes. Lancet 1996;347:1403.
21. Alaeus A, Leitner T, Lidman K, et al. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
22. Balotta C, Facchi G, Violin M, et al. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr 2001;27:499-505.
23. Dietrich U, Ruppach H, Gehring S, et al. Large proportion on non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS 1997;11:1532-33.
24. CM240 HIV-1 in the Finnish injection drug user population. AIDS 2000;14:2613-29.
25. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
26. Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nat Med 1996;2:625-9.
27. Riddler SA, Mellors JW. HIV-1 vital dynamics and viral load measurement: Implications for therapy. AIDS Clin Rev 1997;98:47-65.
28. Murphy DG, Cote L, Fauvel M, et al. Multicenter comparison of Roche COBAS Amplicor Monitor version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Versant version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2000;38:4034-41.
29. Jagodzinski LL, Wiggins DL, McManis JL, et al. Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol 2000;38:1247-9.
30. Alaeus A, Lidman K, Sonnerborg A, et al. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 1997;11:859-65.
31. Parekh B, Phillips S, Granade TC, et al. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999;15:133-42.
32. Jenny-Avital ER, Beatrice ST. Erroneously low or undetectable plasma immunodeficiency virus type 1 (HIV-1) ribonucleic acid load, determined by polymerase chain reaction, in West African and American patients with non-B subtype Hiv-1 infection. Clin Infect Dis 2001;32:1227-30.
33. Elbeik T, Alvord WG, Trichavaroj R, et al. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5. J Acquir Immune Defic Syndr 2002;29:330-9.
34. Dunne AL, Crowe SM. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS 1997;11:126-7.
35. Debyser Z, Van Wungaerden E, Van Laetherm K, et al. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res Hum Retroviruses 1998;14:453-9.
36. Nolte FS, Boysza J, Thurmond C, et al. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription PCR for quantitation of human immunodeficiency virys type 1 RNA in plasma. J Clin Microbiol 1998;36:716-20.
37. Visco-Comandini U, Cappiello G, Liuzzi G, et al. Monophyletic HIV-1 subtype AG recombinant circulating form in a Nosocomial outbreak in Benghazi. AIDS Res Hum Retroviruses 2002; in press.
38. Bland JM, Altman DJ. Comparing methods of measurement: Why plotting difference against standard method is misleading. Lancet 1995;346:1085-7.
39. Holmes H, Davis C, Heath A, et al. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods 2001;92:141-50.
40. Nyambi P, Heyndrickx L, Vereecken K, et al. Predominance of infection with HIV-1 circulating recombinant form CRF02-AG in major Cameroonian cities and towns. AIDS 2002;16:295-305.
41. Tebit DM, Zekeng L, Kaptue L, et al. Genotypic and phenotypic analysis of HIV-type 1 primary isolates from western Cameroon. AIDS Res Hum Retroviruses 2002;18:39-48.
42. Lippincott W, Lippincott W. Predominance of infection with HIV-1 circulating recombinant form CRF02-AG in major Cameroonian cities and towns. AIDS 2002;16:295-305.
43. Damond F, Apetrei C, Descamps D, et al. HIV-1 subtypes and plasma RNA quantification. AIDS 1999;13:286-8.
44. De Baar MP, van der Schoot AM, Goudsmit J, et al. Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target. J Clin Microbiol 1999;37:1813-8.
45. Nkengasong JN, Kalou M, Maurice C, et al. Comparison of NucliSens and Amplicor Monitor assays for quantification of human immunodeficiency virus type 1 RNA in plasma of persons with HIV-1 subtype A infection in Abidijan. Cote d'lvoire. J Clin Microbiol 1998;36:2495-8.
46. Swanson P, Harris BJ, Holzmayer V, et al. Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay. J Virol Methods 2000;89:97-108.
47. Manegold C, Krempe C, Jablonowski H, et al. Comparative evaluation of two branched-DNA human immunodeficiency virus type 1 RNA quantification assays lower detection limits of 50 and 500 copies per milliliter. J Clin Microbiol 2000;38:914-7.
48. CDC. Guidelines for laboratory test result reporting of human immunodeficiency virus type 1 ribonucleic acid determination. MMWR Morb Mortal Wkly Rep 2001;50:1-12.
49. Stenzel MS, Carpenter CC. The management of the clinical complications of antiretroviral therapy. Infect Dis Clin North Am 2000;14:851-78.
50. Zaman MM, Recco RA, Haag R. Infection with non-B subtype HIV type 1 complicates management of established infection in adult patients and diagnosis of infection in newborn infants. Clin Infect Dis 2002;34:417-8.